Ocular itching is the #1 complaint of allergy sufferers.

In a survey of 473 3 adults who suffer from ocular allergies…

 of allergy sufferers experience ocular itching due to allergic conjunctivitis
of allergy sufferers believe ocular itching is an extremely/very bothersome symptom
of allergy sufferers believe it is extremely/very important to alleviate ocular itching

 

 

Click here for references




©2006 Inspire Pharmaceuticals, Inc., Durham, NC 27703 ® Marks owned by Allergan, Inc. Inspire and the Inspire logo are registered trademarks of Inspire Pharmaceuticals, Inc. ELESTAT® is licensed from Boehringer Ingelheim Pty. Ltd., Ingelheim, Germany.


ELESTAT® ophthalmic solution is approved for the prevention of ocular itching associated with allergic conjunctivitis.

Important Safety Information:
ELESTAT® ophthalmic solution is contraindicated in those patients who have shown hypersensitivity to epinastine or to any of the other ingredients.
ELESTAT® is for topical ophthalmic use only and not for injection or oral use. The most frequently reported ocular adverse events occurring in approximately 1-10% of patients were burning sensation in the eye, folliculosis, hyperemia, and pruritus.

Please see Prescribing Information for ELESTAT®.